Heterologous vaccine - Homologous and Heterologous Covid

AU - Nayak, S.

EMA and ECDC recommendations on heterologous vaccination courses against COVID

METHODS In this phase 1β€”2, open-label clinical trial conducted at 10 sites in the United States, adults who had completed a Covid-19 vaccine regimen at least 12 weeks earlier and had no reported history of severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection received a booster injection with one of three vaccines: mRNA-1273 Moderna at a dose of 100 ΞΌg, Ad26.

AU - Deming, M.

Heterologous vaccine


Description: Homologous boosters increased neutralizing antibody titers by a factor of 4 to 20, whereas heterologous boosters increased titers by a factor of 6 to 73.

Views: 6544 Date: 12.04.2022 Favorited: 194 favorites
Category: DEFAULT

User Comments 3

Post a comment

S, and 153 received BNT162b2 as booster vaccines; 1 participant did not receive the assigned vaccine.
But the ministry must assure the people that the use of a heterologous vaccine as a booster dose will have no side effect.

Hot Categories


Latest Comments

    Conclusion: Homologous and heterologous booster vaccinations were well-tolerated and immunogenic in adults who completed a primary Covid-19 vaccine regimen at least 12 weeks earlier. (Funded by National Institute of Allergy and Infectious Diseases; Clinical number, NCT04889209 ). Publication types Preprint Associated data
    By: Demilente|||||||||
    16 December 2021. Departmental news. Reading time: Less than a minute (23 words) The interim recommendations for heterologous COVID-19 vaccine schedules is now published. For further information, see below:
    By: elsyp|||||||||
    Taken together, the investigators concluded, these data strongly suggest that homologous and heterologous booster vaccine will increase protective efficacy against symptomatic SARS-CoV-2 infection
    By: Doggo_Trooper|||||||||
    Homologous and Heterologous Covid-19 Booster Vaccinations Robert L. Atmar, M.D., Kirsten E. Lyke, M.D., Meagan E. Deming, M.D., Ph.D., Lisa A. Jackson, M.D., M.P.H., Angela R. Branche, M.D., Hana .
    By: emisfer|||||||||
    Heterologous immunity is a term used to describe the partial immunity (or altered immunopathology) that occurs in response to a pathogen if the host has been previously infected or immunized with an unrelated pathogen. In some cases, heterologous immunity is attributed to T cells that crossreact with both pathogens.
    By: caddoheart||||||||| - 2022
DISCLAIMER: All models on adult site are 18 years or older. has a zero-tolerance policy against ILLEGAL pornography. All galleries and links are provided by 3rd parties. We have no control over the content of these pages. We take no responsibility for the content on any website which we link to, please use your own discretion while surfing the porn links.
Contact us | Privacy Policy | 18 USC 2257 | DMCA